Clinical trial
Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial
NCT07152249 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 3, 2025
- Completion date
- September 30, 2026
- Enrollment
- 19,480 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
postoperative nausea, postoperative vomiting